The phase III BILCAP study showed improved overall survival after adjuvant capecitabine-based treatment, even if overall survival did not reach statistical significance in the intention-to-treat analysis [ 172 ].
← all excerpts
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.
1
—
—